Key stats
About XTRACKERS SICAV - XTRACKERS MSCI EUROPE HEALTH CARE SCREENED UCITS ETF
Home page
Inception date
Jun 26, 2007
Structure
Luxembourg SICAV
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
DWS Investment SA
ISIN
LU0292103222
The aim is for your investment to reflect the performance of the MSCI Europe Health Care ESG Screened 20-35 Select Index (index).
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.88%
Health Technology99.34%
Commercial Services0.54%
Bonds, Cash & Other0.12%
Mutual fund0.09%
Cash0.03%
Stock breakdown by region
Europe100.00%
North America0.00%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
DXSE invests in stocks. The fund's major sectors are Health Technology, with 99.34% stocks, and Commercial Services, with 0.54% of the basket. The assets are mostly located in the Europe region.
DXSE top holdings are Novartis AG and Roche Holding Ltd Dividend Right Cert., occupying 15.16% and 14.85% of the portfolio correspondingly.
No, DXSE doesn't pay dividends to its holders.
DXSE shares are issued by Deutsche Bank AG under the brand Xtrackers. The ETF was launched on Jun 26, 2007, and its management style is Passive.
DXSE expense ratio is 0.20% meaning you'd have to pay 0.20% of your investment to help manage the fund.
DXSE follows the MSCI Europe Health Care ESG Screened 20-35 Index - EUR. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
DXSE invests in stocks.